Pubblicazioni

Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients

2022 - EXPERT REVIEW OF HEMATOLOGY

Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY

Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

2022 - NATURE COMMUNICATIONS

Niu, Nan; Qiu, Fang; Xu, Qianshi; He, Guijin; Gu, Xi; Guo, Wenbin; Zhang, Dianlong; Li, Zhigao; Zhao, Yi; Li, Yong; Li, Ke; Zhang, Hao; Zhang, Peili; Huang, Yuanxi; Zhang, Gangling; Han, Hongbin; Cai, Zhengang; Li, Pengfei; Xu, Hong; Chen, Guanglei; Xue, Jinqi; Jiang, Xiaofan; Jahromi, Alireza Hamidian; Li, Jinshi; Zhao, Yu; de Faria Castro Fleury, Eduardo; Huo, Shiwen; Li, Huajun; Jerusalem, Guy; Tripodi, Domenico; Liu, Tong; Zheng, Xinyu; Liu, Caigang

Combination strategies involving immune checkpoint inhibitors and tyrosine kinase or BRAF inhibitors in aggressive thyroid cancer

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ragusa, Francesca; Martina Ferrari, Silvia; Elia, Giusy; Rosaria Paparo, Sabrina; Balestri, Eugenia; Botrini, Chiara; Patrizio, Armando; Mazzi, Valeria; Guglielmi, Giovanni; Foddis, Rudy; Spinelli, Claudio; Ulisse, Salvatore; Antonelli, Alessandro; Fallahi, Poupak

Phosphorylation, mgâadp, and inhibitors differentially shape the conformational dynamics of the aâloop of auroraâa

2021 - BIOMOLECULES

Musavizadeh, Z.; Grottesi, A.; Guarguaglini, G.; Paiardini, A.

COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience

2021 - THE BREAST JOURNAL

Barba, M.; Krasniqi, E.; Pizzuti, L.; Mazzotta, M.; Marinelli, D.; Giuliano, G.; Di Liso, F. S.; Cappuzzo, F.; Landi, L.; Tomao, S.; Ciliberto, G.; Vici, P.

Broad kinase inhibition mitigates early neuronal dysfunction in tauopathy

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Koren, Shon A; Hamm, Matthew J; Cloyd, Ryan; Fontaine, Sarah N; Chishti, Emad; Lanzillotta, Chiara; Rodriguez-Rivera, Jennifer; Ingram, Alexandria; Bell, Michelle; Galvis-Escobar, Sara M; Zulia, Nicholas; Di Domenico, Fabio; Duong, Duc; Seyfried, Nicholas T; Powell, David; Vandsburger, Moriel; Frolinger, Tal; Hartz, Anika M S; Koren, John; Axten, Jeffrey M; Laping, Nicholas J; Abisambra, Jose F

Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

2021 - BLOOD

Puzzolo, M. C.; Radice, G.; Peragine, N.; de Propris, M. S.; Mariglia, P.; Vignetti, M.; Vitale, A.; Bassan, R.; Annunziata, M.; Gaidano, G.; Rambaldi, A.; Chiaretti, S.; Guarini, A.; Foa, R.

Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience

2021 - LEUKEMIA & LYMPHOMA

Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Mancini, M.; Diverio, D.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M.

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.

Infantile inflammatory myofibroblastic tumors. Clinicopathological and molecular characterization of 12 cases

2020 - MODERN PATHOLOGY

Lopez-Nunez, O.; John, I.; Panasiti, R. N.; Ranganathan, S.; Santoro, L.; Grelaud, D.; Wu, T.; Buccoliero, A. M.; Casanova, M.; Alaggio, R.; Surrey, L. F.

Is Less More? Intensive Versus Non-Intensive Approach to Adults with Ph+ ALL

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Chiaretti, S.

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

2017 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; FoÃ , Robin

Predictive factors of response to mTOR inhibitors in neuroendocrine tumours

2016 - ENDOCRINE-RELATED CANCER

Zatelli, Maria Chiara; Fanciulli, Giuseppe; Malandrino, Pasqualino; Ramundo, Valeria; Faggiano, Antongiulio; Colao, Annamaria

Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches

2015 - JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Ragno, Rino; Ballante, Flavio; Pirolli, Adele; Wickersham, Richard B; Patsilinakos, Alexandros; Hesse, StÃ©phanie; Perspicace, Enrico; Kirsch, Gilbert

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

2015 - BIOCHEMICAL PHARMACOLOGY

Graziani, Grazia; Artuso, Simona; De Luca, Anastasia; Muzi, Alessia; Rotili, Dante; Scimeca, Manuel; Atzori, Maria Grazia; Ceci, Claudia; Mai, Antonello; Leonetti, Carlo; Levati, Lauretta; Bonanno, Elena; Tentori, Lucio; Caccuri, Anna Maria

Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

2015 - THE JOURNAL OF HEART AND LUNG TRANSPLANTATION

Frost, Adaani E; Barst, Robyn J.; Hoeper, Marius M.; Chang, Hyuk Jae; Frantz, Robert P.; Fukumoto, Yoshihiro; GaliÃ©, Nazzareno; Hassoun, Paul M.; Klose, Hans; Matsubara, Hiromi; Morrell, Nicholas W.; Peacock, Andrew J.; Pfeifer, Michael; Simonneau, GÃ©rald; Tapson, Victor F.; Torres, Fernando; Vizza, Carmine Dario; Lawrence, David; Yang, Wei; Felser, James M.; Quinn, Deborah A.; Ghofrani, Hossein Ardeschir

Widespread renal polycystosis induced by crizotinib

2015 - TUMORI

DI GIROLAMO, Marco; Paris, Ida; Carbonetti, Francesco; Onesti, Elisa Concetta; Socciarelli, Fabio; Marchetti, Paolo

Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront

2015 - LEUKEMIA & LYMPHOMA

Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana

Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib

2015 - BRITISH JOURNAL OF DERMATOLOGY

Fabiano, A.; Calzavara-Pinton, P.; Monari, P.; Moggio, E.; Pellacani, G.; Manganoni, A. M.; Gualdi, G.